JCP Table of Contents

Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison

Nina R. Schooler, Stephen R. Marder, K. N. R. Chengappa, Georgios Petrides, Donna Ames, William C. Wirshing, Marjorie McMeniman, Robert W. Baker, Haranath Parepally, Daniel Umbricht, and John M. Kane

J Clin Psychiatry 2016;77(5):628–634

Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment

Susan G. Ball, Margaret B. Ferguson, James M. Martinez, Beth A. Pangallo, E. Serap Monkul Nery, Mary Anne Dellva, JonDavid Sparks, Qi Zhang, Peng Liu, Mark Bangs, and Celine Goldberger

J Clin Psychiatry 2016;77(5):635–642

The Course of Suicide Risk Following Traumatic Injury

Richard A. Bryant, Meaghan L. O’Donnell, David Forbes, Alexander C. McFarlane, Derrick Silove, and Mark Creamer

J Clin Psychiatry 2016;77(5):648–653

Long-Term Efficacy, Safety, and Tolerability of <span style="font-variant:small-caps;">l</span>-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled #05# [Free]

John M. Zajecka, Maurizio Fava, Richard C. Shelton, Lori W. Barrentine, Page Young, and George I. Papakostas

J Clin Psychiatry 2016;77(5):654–660

Correlation of Clinical Response With Homocysteine Reduction During Therapy With Reduced B Vitamins in Patients With MDD Who Are Positive for <em>MTHFR</em> C677T or A1298C Polymorphism: A Randomized, Double-Blind, Placebo-Controlled Study [Free]

Arnold W. Mech and Andrew Farah

J Clin Psychiatry 2016;77(5):668–671

Age at the Time of Exposure to Trauma Modulates the Psychopathological Profile in Patients With Early Psychosis

Luis Alameda, Philippe Golay, Philipp S. Baumann, Carina Ferrari, Kim Q. Do, and Philippe Conus

J Clin Psychiatry 2016;77(5):e612–e618

Adherence to Antidepressants Is Associated With Lower Mortality: A 4-Year Population-Based Cohort Study

Amir Krivoy, Ran D. Balicer, Becca Feldman, Moshe Hoshen, Gil Zalsman, Abraham Weizman, and Gal Shoval

J Clin Psychiatry 2016;77(5):e566–e572

Comparative Risk of Seizure With Use of First- and Second-Generation Antipsychotics in Patients With Schizophrenia and Mood Disorders

Chi-Shin Wu, Sheng-Chang Wang, I-Jin Yeh, and Shi-Kai Liu

J Clin Psychiatry 2016;77(5):e573–e579

Long-Term Outcome of Early Interventions to Prevent Posttraumatic Stress Disorder

Arieh Y. Shalev, Yael Ankri, Moran Gilad, Yossi Israeli-Shalev, Rhonda Adessky, Meng Qian, and Sara Freedman

J Clin Psychiatry 2016;77(5):e580–e587

Benzodiazepine Use and Risk of Mortality Among Patients With Schizophrenia: A Retrospective Longitudinal Study

Cynthia A. Fontanella, John V. Campo, Gary S. Phillips, Danielle L. Hiance-Steelesmith, Helen Anne Sweeney, Kwok Tam, Douglas Lehrer, Robert Klein, and Mark Hurst

J Clin Psychiatry 2016;77(5):661–667

How Many Treatments Before Clozapine? Medication Choices Across the Spectrum of Treatment Resistance in Schizophrenia [Free]

Peter J. Weiden

J Clin Psychiatry 2016;77(5):e594–e596

The Incidence of Seizures With Antipsychotics [Free]

John M. Davis

J Clin Psychiatry 2016;77(5):e590

Can Development of PTSD Be Prevented After Acute Trauma? [Free]

Barbara Milrod

J Clin Psychiatry 2016;77(5):e588–e589

Benzodiazepine Safety: Mortality Risk or Multiple Chronic Disease Comorbidity? [Free]

Robert A. Rosenheck and Mehmet Sofuoglu

J Clin Psychiatry 2016;77(5):e591–e593

Introduction [Free]

Erika F. H. Saunders

J Clin Psychiatry 2016;77(5):672

Depressive Symptoms Following Stroke and Transient Ischemic Attack: Is It Time for a More Intensive Treatment Approach? Results From the TABASCO Cohort Study

Oren Tene, Shani Shenhar-Tsarfaty, Amos D. Korczyn, Efrat Kliper, Hen Hallevi, Ludmila Shopin, Eitan Auriel, Anat Mike, Natan M. Bornstein, and Einor Ben Assayag

J Clin Psychiatry 2016;77(5):673–680

Quantifying Intraindividual Variations in Plasma Clozapine Levels: A Population Pharmacokinetic Approach

Jimmy Lee, Robert Bies, Hiroyoshi Takeuchi, Gagan Fervaha, Amaal Bhaloo, Valerie Powell, and Gary Remington

J Clin Psychiatry 2016;77(5):681–687

Clinical Outcomes Associated With Comorbid Posttraumatic Stress Disorder Among Patients With Bipolar Disorder

Ives C. Passos, Karen Jansen, Taiane de A. Cardoso, Gabriela D. Colpo, Cristian P. Zeni, Joao Quevedo, Márcia Kauer-Sant’Anna, Giovanna Zunta-Soares, Jair C. Soares, and Flavio Kapczinski

J Clin Psychiatry 2016;77(5):e555–e560

Doxazosin XL Reduces Symptoms of Posttraumatic Stress Disorder in Veterans With PTSD: A Pilot Clinical Trial

Christopher Rodgman, Christopher D. Verrico, Manuela Holst, Daisy Thompson-Lake, Colin N. Haile, Richard De La Garza, Murray A. Raskind, and Thomas F. Newton

J Clin Psychiatry 2016;77(5):e561–e565

Early Onset of Response With Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: A Meta-Analysis

Yasmin Issari, Ewgeni Jakubovski, Christine A. Bartley, Christopher Pittenger, and Michael H. Bloch

J Clin Psychiatry 2016;77(5):e605–e611

Demographic Variables, Design Characteristics, and Effect Sizes of Randomized, Placebo-Controlled, Monotherapy Trials of Major Depressive Disorder and Bipolar Depression

George I. Papakostas, Max A. Martinson, Maurizio Fava, and Nadia Iovieno

J Clin Psychiatry 2016;77(5):e619–e624

Open-Label Trial on the Effects of Memantine in Adults With Obsessive-Compulsive Disorder After a Single Ketamine Infusion [Free]

Carolyn I. Rodriguez, Amanda Levinson, Jordana Zwerling, Donna Vermes, and Helen Blair Simpson

J Clin Psychiatry 2016;77(5):688–689 [letter]

Safety and Efficacy of Electroconvulsive Therapy for Depression in the Presence of Deep Brain Stimulation in Obsessive-Compulsive Disorder [Free]

David L. Rosenthal, Evan Leibu, Amy S. Aloysi, Brian H. Kopell, Wayne K. Goodman, and Charles H. Kellner